What the policy lists
| Prior authorization | listed in the policy |
|---|---|
| Quantity limit | listed in the policy |
Aetna's documents for liraglutide
The plan's own lines
Quoted from the plan's document, word for word.
For Chronic Weight Management
Authorization review
- “baseline body weight above 60 kg” (Saxenda PA with Limit)
- “lost at least 4 percent of baseline body weight OR the patient has continued to maintain their initial 4 percent weight loss” (Saxenda PA with Limit)
- “at least 1 percent reduction in body mass index (BMI) from baseline OR the patient has continued to maintain their initial 1 percent BMI reduction” (Saxenda PA with Limit)
- “baseline BMI corresponding to 30 kg/m2 or greater for adults by international cut-off points based on the Cole Criteria” (Saxenda PA with Limit)
- “completed at least 16 weeks of therapy with the requested drug” (Saxenda PA with Limit)
- “completed at least 12 weeks of therapy on the maintenance dose of the requested drug” (Saxenda PA with Limit)
What this medicine is used for
“Adults with overweight in the presence of at least one weight-related comorbid condition.”
From the FDA label for Saxenda, revised February 25, 2026. The label is shown in English as published. DailyMed. Your doctor decides what it is used for in your case.
Common questions
Does Aetna require prior authorization for liraglutide?
Aetna's published policy lists prior authorization for liraglutide.
Does Aetna have a quantity limit for liraglutide?
Aetna's published policy lists a quantity limit for liraglutide.
How do I see the policy for my own plan and state?
Open the free KAIS guide, pick your plan, your type of plan, your state and your medicine, and it shows the policy your plan publishes, with the link to the plan's own document.
Not medical advice and not a decision on your claim. Your doctor and your plan decide.